Csaba Poroszlai is confirmed CEO of the company by the Board of Directors of Egis.
Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer.
Egis’ products are available in 62 countries around the world.
Egis’ products are available in 62 countries. Our portfolio consists of 642 products. Our main focus lies on treating diseases of the cardiovascular and central nervous systems.
Professional content for our medical and pharmaceutical visitors.
These contents are available with password protection - please contact our representative or require your own account at the Contact menu.
Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.
Cookies necessary for basic functioning
These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.
Functional cookies
In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.
Cookies for statistical purposes
They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Egis’ website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.
Your browser is out of date. Please, use an updated version!